Tag: Radiation
Radiotherapy With Adjuvant Durvalumab No Benefit for Head, Neck Cancer
No improvement seen in two-year progression-free survival for radiotherapy with durvalumab versus radiotherapy with cetuximab
Prior Authorization Leads to Radiation Oncology Treatment Delays, Patient Harm
Additionally, physician survey respondents say prior authorization challenges put strain on clinic staff
Lasting Reduction in Toxicity Seen for MRI-Guided SBRT for Prostate Cancer
Lower cumulative incidence reported for two-year physician-scored toxicity and late-grade ≥2 toxicity with MRI guidance
ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer
One-year progression-free survival, overall survival was 79.4, 89.6 percent; significantly longer survival seen in patients who achieved resectability
2008 to 2020 Saw More Radiologists Involved in Teaching
However, decrease seen in mean trainee participation in teaching radiologists' total workload during same period
Restaging MRI Can Predict Survival With Rectal Cancer
Findings can save some lower-risk patients surgery after chemo, radiation
Protracted Radiation Exposure Linked to Hematologic Cancer Mortality
Protracted low-dose exposure to ionizing radiation linked to mortality due to certain hematologic malignancies
Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer
Findings show equivalent efficacy to moderately fractionated radiotherapy with enhanced convenience
Anatomic Changes Can Be Seen With MRI-Linac for Glioblastoma Patients
74 percent of patients had the same changes from pretreatment to posttreatment with T1 + contrast and MRI-linac lesions
